Mustafa Ibrahim Abbas1, Mai Shakir Mohammed1 and Khalid Abdelsamea Mohamedahmed1,2*
1Department of Hematology and Immunohematology, Faculty of Medical Laboratory Sciences, University of Gezira, Wad Medani, Sudan
2Department of Immunology, Faculty of Medical Laboratory Sciences, University of Gezira, Wad Medani, Sudan
*Corresponding Author: Khalid Abdelsamea Mohamedahmed, Department of Hematology and Department of Immunology, Faculty of Medical Laboratory Sciences, University of Gezira, Wad Medani, Sudan.
Received: March 21, 2023; Published: April 01, 2023
The highly contagious new human severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coagulopathies are now recognized as major causes of mortality. SARS-CoV-2 may be a highly prothrombotic virus that alters the coagulation cascade in unknown ways, causing a steady rise in D-dimer as the severity and extent of micro thrombosis rises .
Keywords: Angiotensin-Converting Enzyme (ACE); Thrombosis; COVID-19
Citation: Khalid Abdelsamea Mohamedahmed., et al. “Determination of ACE Gene Polymorphism Among COVID-19 Patients as Predictive Marker of Increased Risk of Thrombosis". Acta Scientific Clinical Case Reports 4.5 (2023): 01-02.
Copyright: © 2023 Khalid Abdelsamea Mohamedahmed., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.